OCULAR THERAPEUTIX, INC (OCUL) Operating income 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) annual operating income history from SEC filings — each fiscal year as reported.
-$270.0MFY2025 · since FY2016: -$43.3M → -$270.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$270.0M | -57.2% |
| FY2024 | -$171.8M | -108.5% |
| FY2023 | -$82.4M | -4.7% |
| FY2022 | -$78.7M | -0.8% |
| FY2021 | -$78.0M | -24.2% |
| FY2020 | -$62.8M | +26.8% |
| FY2019 | -$85.8M | -45.1% |
| FY2018 | -$59.1M | +4.5% |
| FY2017 | -$61.9M | -42.9% |
| FY2016 | -$43.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OCUL financial trends
OCUL RevenueOCUL Net incomeOCUL Net marginOCUL Gross profitOCUL Gross marginOCUL Operating marginOCUL Operating cash flowOCUL Free cash flowOCUL Capital expendituresOCUL Return on equityOCUL Stock buybacksOCUL Dividends paidOCUL Total assetsOCUL Total liabilitiesOCUL Shareholders’ equityOCUL overview →